Ways to Reduce the Health Risks of Cigarettes in the Next Decade
DOI:
https://doi.org/10.61173/96777t90Keywords:
health, tobacco, nicotineAbstract
In modern life, people are always troubled by various stresses, and many people think that smoking is a good way to relieve stress, so whenever they feel tired or encounter difficulties, they choose to smoke to relieve stress. It is one of the major public health issues worldwide. People are more likely to develop various cancers as the amount of cigarettes they smoke increases. Smoking affects our respiratory system (chronic bronchitis, emphysema), digestive system (overproduction of gastric juice and saliva), and nervous system (mental decline, stroke). Over the past two decades, a series of measures have been taken at the national and scientific levels to address the impact of smoking on human health. In 2004, scientists developed e-cigarettes as an alternative to traditional cigarettes. Later, at the biological level, scientists conducted research on drug treatment and reducing the nicotine content of tobacco leaves, and both made significant discoveries.
References
[1] Doll, R., Peto, R., Boreham, J. and Sutherland, I., 2004. Mortality in relation to smoking: 50 years’ observations on male British doctors. Bmj, 328(7455), p.1519. doi: https://doi. org/10.1136/bmj.38142.554479.AE
[2] Forouzanfar, M.H., Afshin, A., Alexander, L.T., Anderson, H.R., Bhutta, Z.A., Biryukov, S., Brauer, M., Burnett, R., Cercy, K., Charlson, F.J. Cohen, A.J. 2016. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. The lancet,388(10053),рр.1659-1724. doi:https://doi.org/10.1016/S0140-6736(16)31679-8
[3] Aryal, U.R., Bhatta, D.N. 2015. Perceived benefits and health risks of cigarette smoking among young adults: insights from a cross-sectional study. Tobacco Induced Diseases, 13(1), pp.1-8. doi: https://doi.org/10.1186/s12971-015-0044-9
[4] Benowitz, N.L. 2008. Neurobiology of nicotine addiction: implications for smoking cessation treatment. The American Journal of Medicine, 121(4), pp.S3-S10. doi: https://doi. org/10.1016/j.amjmed.2008.01.015 Dean&Francis
[5] Hecht, S.S. 1999. Tobacco smoke carcinogens and lung cancer. Journal of the national cancer institute, 91(14), pp. 1194- 1210. doi: https://doi.org/10.1093/jnci/91.14.1194
[6] Malas, M., van der Tempel, J., Schwartz, R., Minichiello, A., Lightfoot, C., Noormohamed, A., Andrews, J., Zawertailo, L. and Ferrence, R., 2016. Electronic cigarettes for smoking cessation: a systematic review. Nicotine and Tobacco Research, 18(10), pp.1926-1936. doi: https://doi.org/10.1093/ntr/ntw119
[7] Hartmann-Boyce J, McRobbie H, Bullen C, Begh R, Stead LF, Hajek P. Electronic cigarettes for smoking cessation. Cochrane Database Syst Rev. 2016 Sep 14;9(9):CD010216. doi:10.1002/14651858.CD010216.pub3.
[8] Colinas, M. and Goossens, A., 2018. Combinatorial transcriptional control of plant specialized metabolism. Trends in Plant Science, 23(4), pp.324-336.doi: https://doi.org/10.1016/ j.tplants.2017.12.006
[9] Shoji, T., Kajikawa, M. and Hashimoto, T., 2010. Clustered transcription factor genes regulate nicotine biosynthesis in tobacco. The Plant Cell, 22(10), pp.3390-3409. doi: https://doi. org/10.1105/tpc.110.078543
[10] Edwards, K.D., Fernandez-Pozo, N., Drake-Stowe, K., Humphry, M., Evans, A.D., Bombarely, A., Allen, F., Hurst, R., White, B., Kernodle, S.P. and Bromley, J.R., 2017. A reference genome for Nicotiana tabacum enables map-based cloning of homeologous loci implicated in nitrogen utilization efficiency. BMC genomics, 18, pp.1-14.doi:https://doi.org/10.1186/s12864- 017-3791-6
[11] Nagpal, P., Ellis, C.M., Weber, H., Ploense, S.E., Barkawi, L.S., Guilfoyle, T.J., Hagen, G., Alonso, J.M., Cohen, J.D., Farmer, E.E. and Ecker, J.R., 2005. Auxin response factors ARF6 and ARF8 promote jasmonic acid production and flower maturation.doi: https://doi.org/10.1242/dev.01955
[12] Guilfoyle, T.J. and Hagen, G., 2007. Auxin response factors. Current opinion in plant biology, 10(5), pp.453-460.doi: https:// doi.org/10.1016/j.pbi.2007.08.014
[13] Todd, A.T., Liu, E., Polvi, S.L., Pammett, R.T. and Page, J.E., 2010. A functional genomics screen identifies diverse transcription factors that regulate alkaloid biosynthesis in Nicotiana benthamiana. The Plant Journal, 62(4), pp.589-600. doi: https://doi.org/10.1111/j.1365-313X.2010.04186.x
[14] Andrews S (2010) FastQC: a quality control tool for high throughput sequence data. Babraham Bioinformatics. https:// www.bioinformatics.babraham.ac.uk/projects/fastqc/. Accessed 18 July 2021
[15] Lackman, P., González-Guzmán, M., Tilleman, S., Carqueijeiro, I., Pérez, A.C., Moses, T., Seo, M., Kanno, Y., Häkkinen, S.T., Van Montagu, M.C. and Thevelein, J.M., 2011. Jasmonate signaling involves the abscisic acid receptor PYL4 to regulate metabolic reprogramming in Arabidopsis and tobacco. Proceedings of the National Academy of Sciences, 108(14), pp.5891-5896.doi: https://doi.org/10.1073/pnas.1103010108
[16] Pentel PR, LeSage MG. New directions in nicotine vaccine design and use. Adv Pharmacol. 2014;69:553–80.doi:https://doi. org/10.1016/B978-0-12-420118-7.00014-7
[17] Xue S, Schlosburg JE, Janda KD. A new strategy for smoking cessation: characterization of a bacterial enzyme for the degradation of nicotine. J Am Chem Soc. 2015;137(32):10136– 9. doi: https://doi.org/10.1021/jacs.5b06605
[18] Xue S, Kallupi M, Zhou B, Smith LC, Miranda PO, George O, Janda KD. An enzymatic advance in nicotine cessation therapy. Chem Commun (Camb). 2018;54(14):1686–9.
[19] LeSage MG, Keyler DE, Shoeman D, Raphael D, Collins G, Pentel PR. Continuous nicotine infusion reduces nicotine self-administration in rats with 23-h/day access to nicotine. Pharmacol Biochem Behav. 2002;72(1–2):279–89.doi: https:// doi.org/10.1016/S0091-3057(01)00775-4
[20] Hoffman AC, Evans SE. Abuse potential of non-nicotine tobacco smoke components: acetaldehyde, nornicotine, cotinine, and anabasine. Nicotine Tob Res. 2013;15(3):622–32. doi: https://doi.org/10.1093/ntr/nts192
[21] Harris AC, Tally L, Schmidt CE, Muelken P, Stepanov I, Saha S, Vogel RI, LeSage MG. Animal models to assess the abuse liability of tobacco products: effects of smokeless tobacco extracts on intracranial self-stimulation. Drug Alcohol Depend. 2015;147:60–7. doi: https://doi.org/10.1016/ j.drugalcdep.2014.12.015
[22] LeSage MG, Burroughs D, Muelken P, Harris AC. Self- Administration of Smokeless Tobacco Products in rats. Tob Regul Sci. 2016;2(4):329–42.doi: 10.18001/TRS.2.4.5
[23] Anon. The health consequences of smoking: Nicotine addiction, a report of the Surgeon General. Atlanta: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, Office on Smoking and Health; 1988.
[24] Donny EC, Denlinger RL, Tidey JW, Koopmeiners JS, Benowitz NL, Vandrey RG, al’Absi M, Carmella SG, Cinciripini PM, Dermody SS, et al. Randomized trial of reduced-nicotine standards for cigarettes. N Engl J Med. 2015;373(14):1340–9. doi: 10.1056/NEJMsa1502403
Downloads
Published
Issue
Section
License
Copyright (c) 2024 by the authors.
This work is licensed under a Creative Commons Attribution 4.0 International License.
